Summary
The immediate assessment of response to therapy is most beneficial to ovarian cancer patients. This study shows the correlation of drug-induced caspase activation determined by western blot analysis and by Caspase-Glo™ assay. Our findings demonstrate that the use of the Caspase-Glo™ assay allows a simple, fast, and sensitive alternative for the evaluation of in vitro response to chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schwartz, P.E. Current diagnosis and treatment modalities for ovarian cancer. Cancer Treat Res 107, 99–118 (2002).
Kaufmann, S.H. Earnshaw, W.C. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256, 42–9 (2000).
Cohen, G.M. Caspases: the executioners of apoptosis. Biochem J 326 (Pt 1), 1–16 (1997).
Flick, M.B. et al. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients. J Soc Gynecol Investig 11, 252–9 (2004).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press Inc.
About this protocol
Cite this protocol
Alvero, A.B., Montagna, M.K., Mor, G. (2008). Correlation of Caspase Activity and In Vitro Chemo-Response in Epithelial Ovarian Cancer Cell Lines. In: Mor, G., Alvero, A.B. (eds) Apoptosis and Cancer. Methods in Molecular Biology™, vol 414. Humana Press. https://doi.org/10.1007/978-1-59745-339-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-59745-339-4_7
Publisher Name: Humana Press
Print ISBN: 978-1-58829-457-9
Online ISBN: 978-1-59745-339-4
eBook Packages: Springer Protocols